Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril

• Published in: Rossiĭskiĭ kardiologicheskiĭ zhurnal Vol. 25; no. 2; pp. 90 - 97
• Main Authors: Davydkin, I. L., Kuzmina, T. P., Zolotovskaya, I. A., Tereshina, O. V., Danilova, O. E., Khairetdinov, R. K., Rogozina, L. A.
• Format: Journal Article
• Language: Russian
• Published: FIRMA «SILICEA» LLC 11.03.2020
• Subjects: cardiotoxicity; chemotherapy; chronic lymphocytic leukemia; enalapril; subclinical left ventricle contractile dysfunction

Aim. To assess eft ventricular (LV) contractility dysfunction in patients with chronic lymphocytic leukemia (CLL) receiving chemotherapy with fludarabine, cyclophosphamide, and rituximab (FCR), and to determine the enalapril.effectiveness for their treatment. Material and methods. The study included...